{"disease":{"id":"immunogenicity","name":"immunogenicity"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04051268","title":"Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3071,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT03722615","title":"Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"University of Witwatersrand, South Africa","has_results":false},{"nct_id":"NCT05298800","title":"Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Centers for Disease Control and Prevention, China","has_results":false},{"nct_id":"NCT04754698","title":"COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2196,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT03971370","title":"Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"Jiangsu Province Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT04725669","title":"Seroprevalence of Pertussis Among Children and Adolescents in Croatia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"University Hospital for Infectious Diseases, Croatia","has_results":false},{"nct_id":"NCT07256912","title":"A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":1266,"lead_sponsor_name":"International Agency for Research on Cancer","has_results":false},{"nct_id":"NCT03246230","title":"Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity","phase":"NA","overall_status":"COMPLETED","enrollment_count":911,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT05104359","title":"COVID-19 Quantitative Antibody Titers & Booster Vaccinations","phase":"","overall_status":"COMPLETED","enrollment_count":825,"lead_sponsor_name":"Epividian","has_results":false},{"nct_id":"NCT05911087","title":"A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Stemirna Therapeutics","has_results":false},{"nct_id":"NCT03460405","title":"Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT05686161","title":"mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Stemirna Therapeutics","has_results":false},{"nct_id":"NCT03680417","title":"Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT03919578","title":"Protectivity and Safety Following Recombinant Hepatitis B Vaccine","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":536,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT05372575","title":"A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04878822","title":"Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ospedale di Circolo - Fondazione Macchi","has_results":false},{"nct_id":"NCT04756817","title":"Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece","phase":"","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"G.Gennimatas General Hospital","has_results":false},{"nct_id":"NCT04071379","title":"Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT04015232","title":"Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Intas Pharmaceuticals, Ltd.","has_results":true},{"nct_id":"NCT05373030","title":"Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Zhejiang Provincial Center for Disease Control and Prevention","has_results":false},{"nct_id":"NCT05383560","title":"Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":179,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT06497036","title":"Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Geropharm","has_results":false},{"nct_id":"NCT05054621","title":"Immunogenicity of COVID-19 Vaccine on Heterologous Schedule","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05189548","title":"To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":72,"lead_sponsor_name":"Changchun BCHT Biotechnology Co.","has_results":false},{"nct_id":"NCT03681860","title":"EMaBS TB Vaccine Study","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT01092195","title":"Gardasil Vaccination in Post Stem Cell Transplant Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT04961385","title":"Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Bangkok Metropolitan Administration Medical College and Vajira Hospital","has_results":false},{"nct_id":"NCT07429474","title":"Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Laboratorios Sophia S.A de C.V.","has_results":false},{"nct_id":"NCT01369927","title":"Shigella Sonnel O-SPC/rBRU Conjugate Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT07485855","title":"Influenza Vaccination Strategy for Patients With Hematologic Malignancy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT05150834","title":"Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines","phase":"","overall_status":"UNKNOWN","enrollment_count":53,"lead_sponsor_name":"Korea University Guro Hospital","has_results":false},{"nct_id":"NCT06778304","title":"Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"West China Second University Hospital","has_results":false},{"nct_id":"NCT04220073","title":"Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}